127 related articles for article (PubMed ID: 23927694)
1. Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine.
Merki-Feld GS; Imthurn B; Seifert B; Merki LL; Agosti R; Gantenbein AR
Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):394-400. PubMed ID: 23927694
[TBL] [Abstract][Full Text] [Related]
2. Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary study.
Merki-Feld GS; Imthurn B; Langner R; Sándor PS; Gantenbein AR
Cephalalgia; 2013 Apr; 33(5):340-6. PubMed ID: 23297380
[TBL] [Abstract][Full Text] [Related]
3. Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days.
Merki-Feld GS; Imthurn B; Langner R; Seifert B; Gantenbein AR
J Headache Pain; 2015; 16():522. PubMed ID: 25933634
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
5. Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial.
Merki-Feld GS; Imthurn B; Gantenbein AR; Sandor P
Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):175-181. PubMed ID: 31094588
[No Abstract] [Full Text] [Related]
6. Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis.
Warhurst S; Rofe CJ; Brew BJ; Bateson D; McGeechan K; Merki-Feld GS; Garrick R; Tomlinson SE
Cephalalgia; 2018 Apr; 38(4):754-764. PubMed ID: 28554244
[TBL] [Abstract][Full Text] [Related]
7. Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study.
Morotti M; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():178-82. PubMed ID: 25461375
[TBL] [Abstract][Full Text] [Related]
8. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
9. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series.
Novack V; Fuchs L; Lantsberg L; Kama S; Lahoud U; Horev A; Loewenthal N; Ifergane G
Cephalalgia; 2011 Oct; 31(13):1336-42. PubMed ID: 21700645
[TBL] [Abstract][Full Text] [Related]
10. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal C; Thaipisuttikul Y; Pinjaroen S; Krisanapan O; Benjawang W; Koster A; Doesburg W
Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Pinus radiata bark extract and vitamin C combination product as a prophylactic therapy for recalcitrant migraine and long-term results.
Chayasirisobhon S
Acta Neurol Taiwan; 2013 Mar; 22(1):13-21. PubMed ID: 23479241
[TBL] [Abstract][Full Text] [Related]
12. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
13. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
14. Predicting disability and quality of life in a community-based sample of women with migraine headache.
Kolotylo CJ; Broome ME
Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
[TBL] [Abstract][Full Text] [Related]
15. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
16. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
Vree ML; Schmidt J
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
[TBL] [Abstract][Full Text] [Related]
17. [Disability and quality of life in patients with migraine: determining factors].
Fernández-Concepción O; Canuet-Delis L
Rev Neurol; 2003 Jun 16-30; 36(12):1105-12. PubMed ID: 12833226
[TBL] [Abstract][Full Text] [Related]
18. Migraine changes with age: IMPACT on migraine classification.
Kelman L
Headache; 2006; 46(7):1161-71. PubMed ID: 16866720
[TBL] [Abstract][Full Text] [Related]
19. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?
Merki-Feld GS; Imthurn B; Dubey R; Sándor PS; Gantenbein AR
J Obstet Gynaecol; 2017 Apr; 37(3):338-341. PubMed ID: 28129717
[TBL] [Abstract][Full Text] [Related]
20. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
